BALTIMORE — Scientists at the University of Maryland School of Medicine’s Center for Vaccine Development are part of nationwide vaccine research aimed at protecting adults from a new and virulent strain of avian influenza virus.
The virus, called H7N9 influenza virus, emerged in China last spring. As of mid-August, 135 confirmed human cases, including 44 deaths, have been reported by the World Health Organization. The study, sponsored by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), will help prepare for the possibility of a global pandemic.
This bird flu virus. . .
Register or Login to keep reading
Thank you for your interest in accessing the complete content. To continue reading, please register for free. By registering, you'll gain full access to our valuable resources, updates, and insights.
If you already have an account please Log In.
